Drug Profile


Alternative Names: FPL 63547; FPL 63674

Latest Information Update: 22 Dec 1995

Price : $50

At a glance

  • Originator Fisons
  • Class Antihypertensives
  • Mechanism of Action ACE inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 22 Dec 1995 Discontinued-II for Hypertension in United Kingdom (Unknown route)
  • 22 Dec 1995 Discontinued-II for Heart failure in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top